DE69325389D1 - Verfahren zur stabile transformation von weizen - Google Patents

Verfahren zur stabile transformation von weizen

Info

Publication number
DE69325389D1
DE69325389D1 DE69325389T DE69325389T DE69325389D1 DE 69325389 D1 DE69325389 D1 DE 69325389D1 DE 69325389 T DE69325389 T DE 69325389T DE 69325389 T DE69325389 T DE 69325389T DE 69325389 D1 DE69325389 D1 DE 69325389D1
Authority
DE
Germany
Prior art keywords
wheat
transformed
stable transformation
fertile
plants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69325389T
Other languages
English (en)
Other versions
DE69325389T2 (de
DE69325389T3 (de
Inventor
Yin-Fu Chang
James Wong
Andrea Itano
Stephen J Mejza
Leslie Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Participations AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26844765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69325389(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69325389D1 publication Critical patent/DE69325389D1/de
Publication of DE69325389T2 publication Critical patent/DE69325389T2/de
Application granted granted Critical
Publication of DE69325389T3 publication Critical patent/DE69325389T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8206—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
    • C12N15/8207—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated by mechanical means, e.g. microinjection, particle bombardment, silicon whiskers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Cereal-Derived Products (AREA)
  • Noodles (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
DE69325389T 1992-12-16 1993-12-13 Verfahren zur stabilen Transformation von Weizen Expired - Lifetime DE69325389T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99239192A 1992-12-16 1992-12-16
US992391 1992-12-16
US08/147,261 US5610042A (en) 1991-10-07 1993-11-01 Methods for stable transformation of wheat
US147261 1993-11-01
PCT/US1993/012085 WO1994013822A2 (en) 1992-12-16 1993-12-13 Methods for stable transformation of wheat

Publications (3)

Publication Number Publication Date
DE69325389D1 true DE69325389D1 (de) 1999-07-22
DE69325389T2 DE69325389T2 (de) 1999-11-25
DE69325389T3 DE69325389T3 (de) 2007-02-08

Family

ID=26844765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69325389T Expired - Lifetime DE69325389T3 (de) 1992-12-16 1993-12-13 Verfahren zur stabilen Transformation von Weizen

Country Status (10)

Country Link
US (2) US5610042A (de)
EP (1) EP0674715B2 (de)
AT (1) ATE181364T1 (de)
AU (1) AU688297B2 (de)
CA (1) CA2151127C (de)
DE (1) DE69325389T3 (de)
DK (1) DK0674715T4 (de)
ES (1) ES2134925T5 (de)
GR (1) GR3031054T3 (de)
WO (1) WO1994013822A2 (de)

Families Citing this family (255)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605712B1 (en) * 1990-12-20 2003-08-12 Arch Development Corporation Gene transcription and ionizing radiation: methods and compositions
US5610042A (en) * 1991-10-07 1997-03-11 Ciba-Geigy Corporation Methods for stable transformation of wheat
US7262055B2 (en) 1998-08-25 2007-08-28 Gendaq Limited Regulated gene expression in plants
US7285416B2 (en) 2000-01-24 2007-10-23 Gendaq Limited Regulated gene expression in plants
US5631152A (en) * 1994-10-26 1997-05-20 Monsanto Company Rapid and efficient regeneration of transgenic plants
EP0856060A2 (de) 1996-06-21 1998-08-05 Monsanto Company Verfahren zur herstellung stabil-transformiertes fertiles weizen, durch agrobakterium vermittelte transformation und davon abgeleiteten zusammensetzungen
US5773269A (en) * 1996-07-26 1998-06-30 Regents Of The University Of Minnesota Fertile transgenic oat plants
US6002068A (en) * 1996-12-19 1999-12-14 Novartis Finance Corporation Methods for conferring insect resistance to a monocot using a perioxidase coding sequence
US6872871B2 (en) * 1998-02-02 2005-03-29 Odyssey Thera Inc. Mapping molecular interactions in plants with protein fragments complementation assays
US6235529B1 (en) * 1997-04-29 2001-05-22 The Regents Of The University Of California Compositions and methods for plant transformation and regeneration
US7102056B1 (en) 1997-04-29 2006-09-05 The Regents Of The University Of California Compositions and methods for plant transformation and regeneration
MX257801B (en) 1997-06-02 2008-06-10 Syngenta Participations Ag Plant transformation methods
EP1017268A1 (de) * 1997-09-24 2000-07-12 The Regents Of The University Of California Verfahren und zusammensetzung für die transformation von getreiden mittels kultivierten triebmeristemgewebe
EP1019517B2 (de) 1997-09-30 2014-05-21 The Regents of The University of California Herstellung von proteinen in pflanzensamen
US6060315A (en) * 1997-12-01 2000-05-09 Lockheed Martin Energy Research Corporation Method for facilitating the introduction of material into cells
US6153811A (en) 1997-12-22 2000-11-28 Dekalb Genetics Corporation Method for reduction of transgene copy number
CN1206360C (zh) 1998-02-20 2005-06-15 辛甄塔有限公司 杂交种子生产
US5973227A (en) * 1998-05-06 1999-10-26 University Of Saskatchewan Flax transformation
US20050086718A1 (en) 1999-03-23 2005-04-21 Mendel Biotechnology, Inc. Plant transcriptional regulators of abiotic stress
US7897843B2 (en) 1999-03-23 2011-03-01 Mendel Biotechnology, Inc. Transcriptional regulation of plant biomass and abiotic stress tolerance
WO2001033944A1 (en) 1999-11-10 2001-05-17 University Of Washington Compositions and methods for modulation of plant cell division
EP1950306A1 (de) 1999-11-17 2008-07-30 Mendel Biotechnology, Inc. Umweltstress-Toleranzgene
MXPA02004884A (es) 1999-11-17 2004-04-05 Mendel Biotechnology Inc Genes de tolerancia a patogenos.
US6812028B1 (en) * 1999-12-10 2004-11-02 University Of Guelph Embryogenesis and plant regeneration from microspores
US6580019B1 (en) 2000-03-09 2003-06-17 Dekalb Genetics Corporation Non-reciprocal recombination-mediated transgene deletion in transgenic plants
US6750379B2 (en) 2000-03-09 2004-06-15 Dekalb Genetics Corporation Homologous recombination-mediated transgene alterations in plants
US6806399B1 (en) * 2000-04-19 2004-10-19 Carmel-Haifa University Economic Corporation Ltd. Pollen-mediated method for transformation of maize, tomato or melon
US7468475B2 (en) 2000-06-16 2008-12-23 Schmuelling Thomas Method for modifying plant morphology, biochemistry and physiology
US6995016B2 (en) 2000-08-17 2006-02-07 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Process for inducing direct somatic embryogenesis in immature scutella cells of pooideae, and rapidly regenerating fertile plants
EP2410060A1 (de) 2000-08-22 2012-01-25 Mendel Biotechnology, Inc. Gene zum Verändern der Eigenschaften von Pflanzen IV
FR2815969B1 (fr) 2000-10-30 2004-12-10 Aventis Cropscience Sa Plantes tolerantes aux herbicides par contournement de voie metabolique
BR0207857A (pt) 2001-03-06 2004-03-23 Dow Chemical Co Célula de planta tendo uma função de adição de açúcar do tipo animal
WO2002074926A2 (en) * 2001-03-19 2002-09-26 Cargill Incorporated Myo-inositol oxygenases
US20040242523A1 (en) * 2003-03-06 2004-12-02 Ana-Farber Cancer Institue And The Univiersity Of Chicago Chemo-inducible cancer gene therapy
US8034791B2 (en) 2001-04-06 2011-10-11 The University Of Chicago Activation of Egr-1 promoter by DNA damaging chemotherapeutics
ES2380007T3 (es) * 2001-04-06 2012-05-07 The University Of Chicago Inducción por agentes quimioterapéuticos de la actividad del promotor Egr-1 en la terapia génica
JP4338402B2 (ja) 2001-05-22 2009-10-07 ユニバーシティ オブ シカゴ Ｎ４ウイルス一本鎖ｄｎａ依存的ｒｎａポリメラーゼ
JP4771656B2 (ja) 2001-05-30 2011-09-14 カリックス・バイオ−ベンチャーズ・インコーポレイテッド 植物人工染色体、その使用及び植物人工染色体の製造方法
BR0213965A (pt) * 2001-10-26 2005-03-15 Baylor College Medicine Composição e método para alterar as propriedades de massa corporal magra e ósseas em um indivìduo
WO2003049700A2 (en) 2001-12-11 2003-06-19 Advisys, Inc. Growth hormone releasing hormone suplementation for treating chronically ill subjects
US20030166282A1 (en) * 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
ATE529512T1 (de) * 2002-02-01 2011-11-15 Life Technologies Corp Doppelsträngige oligonukleotide
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
EP1549133B1 (de) 2002-05-22 2015-04-22 Monsanto Technology LLC Fettsäuredesaturasen von pilzen
US20040248094A1 (en) * 2002-06-12 2004-12-09 Ford Lance P. Methods and compositions relating to labeled RNA molecules that reduce gene expression
WO2004001003A2 (en) 2002-06-20 2003-12-31 Board Of Trustees Operating Michigan State University Plastid division and related genes and proteins, and methods of use
AU2003304195B8 (en) 2002-07-15 2008-08-28 Board Of Regents, The University Of Texas System Combinatorial protein library screening by periplasmic expression
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
US20040029275A1 (en) * 2002-08-10 2004-02-12 David Brown Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
EP1578396A4 (de) 2002-08-12 2007-01-17 David Kirn Verfahren und zusammensetzungen gegen pockenviren und krebs
US7429691B2 (en) * 2002-09-03 2008-09-30 The Regents Of The University Of California Methods and compositions for transformation and regeneration of maize
EP2272962B1 (de) 2002-09-18 2017-01-18 Mendel Biotechnology, Inc. Polynukleotide und Polypeptide in Pflanzen
US7404950B2 (en) * 2003-02-18 2008-07-29 Baylor College Of Medicine Induced activation in dendritic cell
TW200424214A (en) * 2003-04-21 2004-11-16 Advisys Inc Plasmid mediated GHRH supplementation for renal failures
US7655833B2 (en) 2003-05-29 2010-02-02 Brookhaven Science Associates, Llc ADS genes for reducing saturated fatty acid levels in seed oils
EP2290084A3 (de) 2003-06-30 2011-10-12 Commonwealth Scientific and Industrial Research Organization Weizen mit veränderter Verzweigungsenzymaktivität und daraus abgeleitete Stärke-haltige Produkte
WO2006023869A2 (en) 2004-08-24 2006-03-02 Monsanto Technology Llc Adenylate translocator protein gene non-coding regulatory elements for use in plants
ES2444001T3 (es) 2004-10-21 2014-02-21 Venganza Inc. Procedimientos y materiales para conferir resistencia a plagas y patógenos de plantas
ES2534304T3 (es) 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
CN100362104C (zh) 2004-12-21 2008-01-16 华中农业大学 利用水稻转录因子基因OsNACx提高植物抗旱耐盐能力
AR053269A1 (es) 2005-05-16 2007-04-25 Monsanto Technology Llc Plantas y semillas de maiz con mejoramiento de asparagina y proteina
WO2006125065A2 (en) 2005-05-18 2006-11-23 The Board Of Trustees Operating Michigan State University Resistance to soybean aphid in early maturing soybean germplasm
EP2422615B1 (de) 2005-07-29 2014-06-18 Targeted Growth, Inc. Dominant-negative KRP-Proteinmutante als Schutz gegen die Hemmung von aktivem Cyclin-CDK-Komplex durch Wildtyp-KRP
US20070059833A1 (en) * 2005-09-07 2007-03-15 Maxcyte, Inc. Use of Nucleases to Improve Viability and Enhance Transgene Expression in Transfected Cells
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
CA2621982C (en) * 2005-09-07 2017-11-28 Jennerex Biotherapeutics Ulc Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
BRPI0619837A2 (pt) 2005-12-15 2011-10-18 Targeted Growth Inc método para aumentar o tamanho de semente de uma planta e/ou para aumentar o número de sementes obtenìveis de uma planta, construção genética e métodos para a produção de uma planta transgênica
US7663020B2 (en) * 2006-01-11 2010-02-16 Agrinomics Llc Generation of plants with altered oil content
CA2637598A1 (en) 2006-01-18 2007-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
US7868228B2 (en) 2006-01-31 2011-01-11 Monsanto Technology Llc Phosphopantetheinyl transferases from bacteria
US7820883B2 (en) 2006-03-15 2010-10-26 Dow Agrosciences Llc Resistance to auxinic herbicides
US8304239B2 (en) 2006-03-31 2012-11-06 Reliance Life Sciences Pvt Ltd. Direct regeneration of plantlets in Jatropha curcas
US7977535B2 (en) 2006-07-12 2011-07-12 Board Of Trustees Of Michigan State University DNA encoding ring zinc-finger protein and the use of the DNA in vectors and bacteria and in plants
WO2008014484A1 (en) 2006-07-27 2008-01-31 University Of Maryland, Baltimore Cellular receptor for antiproliferative factor
JP5606067B2 (ja) 2006-09-15 2014-10-15 オタワ ホスピタル リサーチ インスティテュート 腫瘍崩壊性ラブドウイルス
PL2121935T3 (pl) 2006-09-25 2011-12-30 Schmuelling Thomas Transkrypcyjne represory szlaków sygnałowych cytokinin i ich zastosowanie
US8691210B2 (en) * 2006-10-19 2014-04-08 David M Spencer Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
AU2007351787A1 (en) * 2006-10-20 2008-10-30 Arizona Board Of Regents For And On Behalf Of Arizona State University Modified cyanobacteria
CA2669989A1 (en) 2006-11-15 2008-05-22 Agrigenetics, Inc. Generation of plants with altered protein, fiber, or oil content
CA2988382A1 (en) * 2006-11-15 2008-05-22 Agrigenetics, Inc. Generation of plants with altered protein, fiber, or oil content
US8030541B2 (en) * 2006-11-15 2011-10-04 Dow Agrosciences Llc Generation of plants with altered protein, fiber, or oil content
WO2008079545A2 (en) * 2006-11-15 2008-07-03 Agrigenetics, Inc. Generation of plants with altered protein, fiber, or oil content
CA2669900C (en) 2006-11-15 2016-03-01 Agrigenetics, Inc. Generation of plants expressing an imq polypeptide and having altered protein, fiber or oil content
EP2102239B1 (de) 2006-11-30 2012-04-25 Research Development Foundation Verbesserte immunglobulin-bibliotheken
WO2008076980A2 (en) 2006-12-15 2008-06-26 Agrigenetics, Inc. Generation of plants with altered oil, protein, or fiber content
MX2009006465A (es) * 2006-12-15 2009-08-21 Agrinomics Llc Generacion de plantas con contenido de aceite, proteina o fibra alterado.
CN101600342A (zh) * 2006-12-15 2009-12-09 农业经济有限责任公司 具有改变的油、蛋白或纤维含量的植物的生产
BRPI0720302A2 (pt) * 2006-12-15 2014-02-04 Agrinomics Llc Produção de plantas com conteúdo alterado de óleos, proteínas ou fibras
WO2008076831A2 (en) * 2006-12-15 2008-06-26 Agrinomics Llc Generation of plants with altered oil, protein, or fiber content
KR20080084528A (ko) 2007-03-15 2008-09-19 제네렉스 바이오테라퓨틱스 인크. 종양살상형 백시니아 바이러스 암 치료
US8629245B2 (en) 2007-05-01 2014-01-14 Research Development Foundation Immunoglobulin Fc libraries
WO2008157559A2 (en) * 2007-06-18 2008-12-24 Agrinomics Llc Generation of plants with altered oil, protein or fiber content
WO2009029831A1 (en) 2007-08-31 2009-03-05 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
KR101588736B1 (ko) 2008-01-10 2016-01-26 리서치 디벨롭먼트 파운데이션 얼리키아 샤피엔시스에 대한 백신 및 진단제
JP5674476B2 (ja) 2008-01-25 2015-02-25 ピー５３ インコーポレイテッド Ｐ５３バイオマーカー
CA2954948A1 (en) 2008-06-04 2009-12-10 Cellular Dynamics International, Inc. Methods for the production of ips cells using non-viral approach
CN107988261A (zh) 2008-08-12 2018-05-04 细胞动力国际有限公司 产生ips细胞的方法
AU2009282625A1 (en) 2008-08-18 2010-02-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Derivatives of APF and methods of use
JP6133538B2 (ja) 2008-09-22 2017-05-24 ベイラー カレッジ オブ メディスンＢａｙｌｏｒ Ｃｏｌｌｅｇｅ Ｏｆ Ｍｅｄｉｃｉｎｅ Ｃｄ４０およびパターン認識受容体アダプターを誘発することによる免疫応答を生成するための方法および組成物
AU2009302582A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
US8329994B2 (en) 2008-10-14 2012-12-11 Monsanto Technology Llc Utilization of fatty acid desaturases from Hemiselmis spp
US9133475B2 (en) 2008-11-26 2015-09-15 Board Of Trustees Of Michigan State University Aphid resistant soybean plants
JP5651125B2 (ja) 2008-12-10 2015-01-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｍｅｋ阻害剤に対する耐性を付与するｍｅｋ突然変異
US8362318B2 (en) 2008-12-18 2013-01-29 Board Of Trustees Of Michigan State University Enzyme directed oil biosynthesis in microalgae
JP2012515532A (ja) 2009-01-20 2012-07-12 ラモット アット テル アビブ ユニバーシティ， リミテッド Ｍｉｒ−２１プロモーター駆動性標的がん治療
WO2010096510A2 (en) 2009-02-17 2010-08-26 Edenspace Systems Corporation Tempering of cellulosic biomass
KR101773368B1 (ko) 2009-04-03 2017-08-31 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
EP3061766B1 (de) 2009-04-28 2019-12-25 Vanderbilt University Zusammensetzungen und verfahren zur behandlung von erkrankungen im zusammenhang mit epithelzellapoptose
US20120079627A1 (en) 2009-05-29 2012-03-29 Edenspace Systems Corporation Plant gene regulatory elements
CN102459575A (zh) 2009-06-05 2012-05-16 细胞动力国际有限公司 重编程t细胞和造血细胞的方法
WO2011025826A1 (en) 2009-08-26 2011-03-03 Research Development Foundation Methods for creating antibody libraries
WO2011032180A1 (en) 2009-09-14 2011-03-17 Jennerex, Inc. Oncolytic vaccinia virus combination cancer therapy
US8937214B2 (en) 2009-10-23 2015-01-20 Monsanto Technology Llc Methods and compositions for expression of transgenes in plants
EP2510088B1 (de) 2009-12-10 2016-10-05 Ottawa Hospital Research Institute Onkolytisches rhabdovirus
WO2011082253A2 (en) 2009-12-30 2011-07-07 Board Of Trustees Of Michigan State University A method to produce acetyldiacylglycerols (ac-tags) by expression ofan acetyltransferase gene isolated from euonymus alatus (burning bush)
WO2011100508A2 (en) 2010-02-12 2011-08-18 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and compositions related to glycoprotein-immunoglobulin fusions
MX340392B (es) 2010-02-25 2016-07-06 Dana Farber Cancer Inst Inc Mutaciones del protooncogen de serina/treonina-proteina cinasa b-raf (braf) que confieren resistencia a los inhibidores del protooncogen de serina/treonina-proteina cinasa b-raf.
EP2542678B1 (de) 2010-03-04 2017-04-12 InteRNA Technologies B.V. Mirna-molekül, das durch seine quelle definiert ist, und seine therapeutischen verwendungen bei emt assoziierten krebs
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
WO2011126976A1 (en) 2010-04-07 2011-10-13 Vanderbilt University Reovirus vaccines and methods of use therefor
DK2560672T3 (en) 2010-04-19 2014-03-17 Res Dev Foundation RTEF-1 variants and their uses
BR112012029422A2 (pt) 2010-05-19 2017-10-03 The Samuel Roberts Noble Found Inc Morfologia de folha alterada e propriedades agronômicas melhoradas em plantas
WO2011146862A1 (en) 2010-05-21 2011-11-24 Bellicum Pharmaceuticals, Inc. Methods for inducing selective apoptosis
EP3333259B1 (de) 2010-06-09 2021-02-24 Dana Farber Cancer Institute, Inc. Mek1-mutation für resistenz gegenüber raf- und mek-hemmern
CA2802087A1 (en) 2010-06-15 2011-12-22 Cellular Dynamics International, Inc. A compendium of ready-built stem cell models for interrogation of biological response
CN103003416B (zh) 2010-06-15 2016-11-16 细胞动力学国际有限公司 从小体积的外周血产生诱导性多潜能干细胞
CN103037885B (zh) 2010-07-02 2015-08-26 芝加哥大学 与蛋白A(SpA)变体相关的组合物和方法
CA2804599C (en) 2010-07-06 2023-01-31 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
US8785192B2 (en) 2010-07-07 2014-07-22 Cellular Dynamics International, Inc. Endothelial cell production by programming
US8765470B2 (en) 2010-08-04 2014-07-01 Cellular Dynamics International, Inc. Reprogramming immortalized B-cells to induced pluripotent stem cells
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
CN103501803B (zh) 2010-09-22 2015-12-02 科罗拉多大学董事会 Smad7的治疗应用
US9045549B2 (en) 2010-11-03 2015-06-02 The Samuel Roberts Noble Foundation, Inc. Transcription factors for modification of lignin content in plants
AU2012204467B2 (en) 2011-01-04 2016-08-18 Sillajen, Inc. Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
EP2474617A1 (de) 2011-01-11 2012-07-11 InteRNA Technologies BV MIR zur Behandlung von Neoangiogenese
CA2826467C (en) 2011-02-07 2019-11-12 Research Development Foundation Engineered immunoglobulin fc polypeptides
JP6005666B2 (ja) 2011-02-08 2016-10-12 セルラー ダイナミクス インターナショナル， インコーポレイテッド プログラミングによる造血前駆細胞の生産
EP3406628A1 (de) 2011-04-08 2018-11-28 Evaxion Biotech ApS In impfstoffen gegen staphylococcus aureus nützliche proteine und nukleinsäuren
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US8901371B2 (en) 2011-05-06 2014-12-02 The Samuel Roberts Noble Foundation, Inc. Compositions and methods for improved plant feedstock
WO2012170304A2 (en) 2011-06-02 2012-12-13 The Regents Of The University Of California Plants with elevated levels of glucan
EP2718427B1 (de) 2011-06-08 2017-01-11 Children's Hospital of Eastern Ontario Research Institute Inc. Zusammensetzungen zur behandlung von glioblastomen
WO2013005211A2 (en) 2011-07-05 2013-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Boron complexing plant materials and uses thereof cross-reference to related applications
EP2732029B1 (de) 2011-07-11 2019-01-16 FUJIFILM Cellular Dynamics, Inc. Verfahren zur zellprogrammierung und genommanipulation
CA2845259A1 (en) 2011-08-15 2013-02-21 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein a
WO2013026015A1 (en) 2011-08-18 2013-02-21 Dana-Farber Cancer Institute, Inc. Muc1 ligand traps for use in treating cancers
US9273102B2 (en) 2011-10-12 2016-03-01 Niels Iversen Møller Peptides derived from Campylobacter jejuni and their use in vaccination
ES2886147T3 (es) 2011-12-22 2021-12-16 Interna Tech B V MiARN para el tratamiento del cáncer de cabeza y de cuello
EP2844275B1 (de) 2012-04-26 2020-05-13 University of Chicago Staphylokokken-coagulase-antigene und verfahren zu deren verwendung
CA2910320A1 (en) 2012-04-26 2013-10-31 University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
WO2014022455A1 (en) 2012-07-31 2014-02-06 The Board Of Regents Of The University Of Texas System Methods and compositions for in vivo induction of pancreatic beta cell formation
AU2013317586B2 (en) 2012-09-24 2017-12-07 Seminis Vegetable Seeds, Inc. Methods and compositions for extending shelf life of plant products
WO2014065945A1 (en) 2012-10-23 2014-05-01 The Board Of Regents Of The University Of Texas System Antibodies with engineered igg fc domains
US10201556B2 (en) 2012-11-06 2019-02-12 Interna Technologies B.V. Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
CA2836403A1 (en) 2013-01-04 2014-07-04 Board Of Trustees Of Michigan State University New sources of aphid resistance in soybean plants
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
RU2684211C2 (ru) 2013-02-21 2019-04-04 Тёрнстоун Лимитед Партнершип Композиция вакцины
WO2014130770A1 (en) 2013-02-22 2014-08-28 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
US10086093B2 (en) 2013-02-28 2018-10-02 The General Hospital Corporation miRNA profiling compositions and methods of use
WO2014132137A2 (en) 2013-03-01 2014-09-04 Université De Genève Transgenic cell selection
US10456448B2 (en) 2013-03-08 2019-10-29 The Regents Of The University Of Colorado, A Body Corporate PTD-SMAD7 therapeutics
US9434935B2 (en) 2013-03-10 2016-09-06 Bellicum Pharmaceuticals, Inc. Modified caspase polypeptides and uses thereof
EP2968502B1 (de) 2013-03-14 2020-08-26 Bellicum Pharmaceuticals, Inc. Verfahren zur steuerung einer t-zellen-proliferation
WO2014197638A2 (en) 2013-06-05 2014-12-11 Bellicum Pharmaceuticals, Inc. Methods for inducing partial apoptosis using caspase polypeptides
AU2014317861B2 (en) 2013-09-09 2019-11-28 Figene, Llc Gene therapy for the regeneration of chondrocytes or cartilage type cells
WO2015070050A1 (en) 2013-11-08 2015-05-14 Baylor Research Institute Nuclear loclization of glp-1 stimulates myocardial regeneration and reverses heart failure
WO2015070009A2 (en) 2013-11-08 2015-05-14 The Board Of Regents Of The University Of Texas System Vh4 antibodies against gray matter neuron and astrocyte
WO2015082536A1 (en) 2013-12-03 2015-06-11 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
US10392629B2 (en) 2014-01-17 2019-08-27 Board Of Trustees Of Michigan State University Increased caloric and nutritional content of plant biomass
EP3099719B1 (de) 2014-01-29 2020-04-01 Dana-Farber Cancer Institute, Inc. Antikörper gegen die muc1-c/extrazelluläre domäne (/muc1-c/ecd)
CN106132423B (zh) 2014-02-14 2020-07-31 贝里坤制药股份有限公司 用诱导型嵌合多肽活化t细胞的方法
WO2015123561A2 (en) 2014-02-14 2015-08-20 University Of Utah Research Foundation Methods and compositions for inhibiting retinopathy of prematurity
CA2940765A1 (en) 2014-02-25 2015-09-03 Research Development Foundation Sty peptides for inhibition of angiogenesis
CN106102452B (zh) 2014-03-07 2018-09-28 先锋国际良种公司 用于提取单子叶植物胚芽的方法和系统
US20170107486A1 (en) 2014-04-21 2017-04-20 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
WO2015193653A1 (en) 2014-06-16 2015-12-23 Consejo Nacional De Investigaciones Cientificas Y Tecnicas Oxidative resistance chimeric genes and proteins, and transgenic plants including the same
AU2015312117A1 (en) 2014-09-02 2017-03-02 Bellicum Pharmaceuticals, Inc. Costimulation of chimeric antigen receptors by Myd88 and CD40 polypeptides
CN108064298A (zh) 2014-09-11 2018-05-22 马罗内生物创新公司 铁杉下色杆菌(chromobacterium subtsugae)基因组
AU2015341481C1 (en) 2014-11-03 2021-09-16 ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) T cell receptors directed against Bob1 and uses thereof
EP3218497A1 (de) 2014-11-12 2017-09-20 NMC Inc. Transgene pflanzen mit manipulierter redoxempfindlicher modulation von komplexen pigmenten fotosynthetischer antennen und verfahren zur herstellung davon
US20180169211A1 (en) 2014-11-13 2018-06-21 Evaxion Biotech Aps Peptides derived from acinetobacter baumannii and their use in vaccination
JP6720176B2 (ja) 2014-12-15 2020-07-08 ベリカム ファーマシューティカルズ， インコーポレイテッド 治療用細胞のコントロールされた活性化または排除のための方法
WO2016113252A2 (en) 2015-01-12 2016-07-21 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting klebsiella pneumoniae
EP3250675A1 (de) 2015-01-28 2017-12-06 SABIC Global Technologies B.V. Verfahren und zusammensetzungen zum hocheffizienten herstellung von biokraftstoff und/oder biomasse
CA2976236A1 (en) 2015-02-09 2016-08-18 Research Development Foundation Engineered immunoglobulin fc polypeptides displaying improved complement activation
WO2016134293A1 (en) 2015-02-20 2016-08-25 Baylor College Of Medicine p63 INACTIVATION FOR THE TREATMENT OF HEART FAILURE
JP2018510627A (ja) 2015-03-10 2018-04-19 レイデン ユニバーシティ メディカル センター メラノーマ優先発現抗原に対して向けられたｔ細胞レセプターおよびその使用
WO2017005670A1 (en) 2015-07-04 2017-01-12 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
US10526408B2 (en) 2015-08-28 2020-01-07 Research Development Foundation Engineered antibody FC variants
DK3365435T3 (da) 2015-10-20 2021-04-06 Fujifilm Cellular Dynamics Inc Produktion af hæmatopoietiske prækursorceller med multi-afstamning med genetisk programmering
MX2018005274A (es) 2015-10-30 2019-09-19 The Regents Of The Universtiy Of California Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
LT3370733T (lt) 2015-11-02 2021-10-25 Board Of Regents, The University Of Texas System Cd40 aktyvinimo ir imuninės kontrolės taškų blokados būdai
US20190038713A1 (en) 2015-11-07 2019-02-07 Multivir Inc. Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
PL3373968T3 (pl) 2015-11-09 2024-08-05 The Children's Hospital Of Philadelphia Glipikan 2 jako marker nowotworowy i cel terapeutyczny
EP3419654B1 (de) 2016-02-22 2022-04-27 Evaxion Biotech A/S In impfstoffen gegen staphylococcus aureus nützliche proteine und nukleinsäuren
CA3019635A1 (en) 2016-03-31 2017-10-05 Baylor Research Institute Angiopoietin-like protein 8 (angptl8)
WO2017216384A1 (en) 2016-06-17 2017-12-21 Evaxion Biotech Aps Vaccination targeting ichthyophthirius multifiliis
WO2017220787A1 (en) 2016-06-24 2017-12-28 Evaxion Biotech Aps Vaccines against aearomonas salmonicida infection
JP7099967B2 (ja) 2016-07-01 2022-07-12 リサーチ ディベロップメント ファウンデーション 幹細胞由来移植片からの増殖性細胞の排除
WO2018015575A1 (en) 2016-07-22 2018-01-25 Evaxion Biotech Aps Chimeric proteins for inducing immunity towards infection with s. aureus
WO2018035429A1 (en) 2016-08-18 2018-02-22 Wisconsin Alumni Research Foundation Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r
BR112019003577A2 (pt) 2016-08-22 2019-05-21 Biolumic Ltd métodos de tratamento da semente e produtos resultantes
CN109963590B (zh) 2016-09-02 2024-03-15 加利福尼亚大学董事会 涉及白介素-6受体α结合单链可变片段的方法和组合物
AU2017340634B2 (en) 2016-10-05 2022-06-02 FUJIFILM Cellular Dynamics, Inc. Generating mature lineages from induced pluripotent stem cells with MECP2 disruption
EP3523423B1 (de) 2016-10-05 2024-07-31 FUJIFILM Cellular Dynamics, Inc. Verfahren zur gerichteten differenzierung pluripotenter stammzellen von homozygoten hla-immunzellen
RU2646108C1 (ru) * 2016-12-07 2018-03-01 Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова РАН Способ получения трансгенных растений пшеницы с использованием биобаллистики
AU2017375958A1 (en) 2016-12-12 2019-07-04 Multivir Inc. Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
EP3565576A1 (de) 2017-01-05 2019-11-13 Evaxion Biotech ApS Impfstoffe gegen pseudomonas aeruginosa
BR112019018059A2 (pt) 2017-03-07 2020-08-04 BASF Agricultural Solutions Seed US LLC molécula de ácido nucleico recombinante, célula hospedeira, plantas, sementes transgênicas, polipeptídeo recombinante, método para produzir um polipeptídeo, método de controle de ervas daninhas, uso do ácido nucleico e produto de utilidade
CA3055389A1 (en) 2017-03-07 2018-09-13 BASF Agricultural Solutions Seed US LLC Hppd variants and methods of use
KR102668891B1 (ko) 2017-04-18 2024-05-29 후지필름 셀룰러 다이내믹스, 인코포레이티드 항원-특이적 면역 이펙터 세포
EP3621988A1 (de) 2017-05-09 2020-03-18 Bellicum Pharmaceuticals, Inc. Verfahren zur verstärkung oder änderung der signaltransduktion
WO2019038594A2 (en) 2017-08-21 2019-02-28 Biolumic Limited TRANSGENIC PLANTS WITH HIGH GROWTH AND HIGH RUSTICITY
AU2018358016A1 (en) 2017-11-03 2020-05-07 Interna Technologies B.V. MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
US11612618B2 (en) 2017-11-14 2023-03-28 Henry Ford Health System Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
JP2021509815A (ja) 2018-01-05 2021-04-08 オタワ ホスピタル リサーチ インスティチュート 改変ワクシニアベクター
WO2019145399A1 (en) 2018-01-24 2019-08-01 Evaxion Biotech Aps Vaccines for prophylaxis of s. aureus infections
AU2019322487B2 (en) 2018-03-19 2024-04-18 Multivir Inc. Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer
CA3133899A1 (en) 2018-03-30 2019-10-03 University Of Geneva Micro rna expression constructs and uses thereof
WO2020069313A2 (en) 2018-09-28 2020-04-02 Henry Ford Health System Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
WO2020083904A1 (en) 2018-10-22 2020-04-30 Evaxion Biotech Aps Vaccines targeting m. catharrhalis
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
US20220143168A1 (en) 2019-02-27 2022-05-12 Evaxion Biotech A/S Vaccines targeting H. influenzae
WO2020212756A2 (en) 2019-04-18 2020-10-22 Genkin Dmitry Dmitrievich Reprogramming of polymorphonuclear leukocytes
EP3999546A1 (de) 2019-07-19 2022-05-25 The Children's Hospital of Philadelphia Chimäre antigenrezeptoren mit glypican-2-bindungsdomänen
EP4045044A1 (de) 2019-10-18 2022-08-24 The Regents Of The University Of California Plxdc-aktivatoren und ihre verwendung zur behandlung von blutgefässstörungen
WO2021113644A1 (en) 2019-12-05 2021-06-10 Multivir Inc. Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
EP4087593A1 (de) 2020-01-06 2022-11-16 Evaxion Biotech A/S Impfstoffe, die gegen neisseria gonorrhoeae gerichtet sind
EP4157864A1 (de) 2020-05-27 2023-04-05 Antion Biosciences SA Adaptermoleküle zur umleitung von car-t-zellen zu einem antigen von interesse
IL298085A (en) 2020-05-29 2023-01-01 Fujifilm Cellular Dynamics Inc Retinal pigment epithelium and bicellular photoreceptor aggregates and methods of using them
MX2022015002A (es) 2020-05-29 2023-03-03 Fujifilm Cellular Dynamics Inc Bicapa del epitelio pigmentario de la retina y fotorreceptores y uso de los mismos.
WO2022053130A1 (en) 2020-09-09 2022-03-17 Sid Alex Group, S.R.O. Antago-mir-155 for treatment of v-src, c-src-tyrosine kinase-induced cancers
EP4263600A1 (de) 2020-12-18 2023-10-25 Century Therapeutics, Inc. Chimäre antigenrezeptorsysteme mit anpassbarer rezeptorspezifität
EP4291216A1 (de) 2021-02-09 2023-12-20 University of Houston System Onkolytisches virus zur systemischen abgabe und verbesserten antitumorwirkungen
US20240122865A1 (en) 2021-02-19 2024-04-18 Pfizer Inc. Methods of Protecting RNA
MX2023011931A (es) 2021-04-08 2023-12-15 Janssen Biotech Inc Materiales y métodos para mejorar la ingenieria de células t de memoria similares a células madre.
BR112023021993A2 (pt) 2021-05-03 2024-02-20 Astellas Inst For Regenerative Medicine Métodos de geração de células endoteliais da córnea madura
CN117716020A (zh) 2021-05-07 2024-03-15 安斯泰来再生医药协会 产生成熟肝细胞的方法
WO2022251443A1 (en) 2021-05-26 2022-12-01 FUJIFILM Cellular Dynamics, Inc. Methods to prevent rapid silencing of genes in pluripotent stem cells
EP4366762A1 (de) 2021-07-05 2024-05-15 Evaxion Biotech A/S Impfstoffe gegen neisseria gonorrhoeae
WO2023081813A1 (en) 2021-11-05 2023-05-11 St. Jude Children's Research Hospital, Inc. Zip cytokine receptors
WO2023081894A2 (en) 2021-11-08 2023-05-11 St. Jude Children's Research Hospital, Inc. Pre-effector car-t cell gene signatures
EP4436595A1 (de) 2021-11-22 2024-10-02 Pfizer Inc. Verringerung des risikos von antigen-mimetika in immunogenen arzneimitteln
GB2614309A (en) 2021-12-24 2023-07-05 Stratosvir Ltd Improved vaccinia virus vectors
WO2023144779A1 (en) 2022-01-28 2023-08-03 Pfizer Inc. Coronavirus antigen variants
US20230295661A1 (en) 2022-03-16 2023-09-21 University Of Houston System Persistent hsv gene delivery system
WO2023213393A1 (en) 2022-05-04 2023-11-09 Evaxion Biotech A/S Staphylococcal protein variants and truncates
GB202206507D0 (en) 2022-05-04 2022-06-15 Antion Biosciences Sa Expression construct
WO2023240109A1 (en) 2022-06-07 2023-12-14 Regeneron Pharmaceuticals, Inc. Multispecific molecules for modulating t-cell activity, and uses thereof
WO2023240182A1 (en) 2022-06-08 2023-12-14 St. Jude Children's Research Hospital, Inc. Disruption of kdm4a in t cells to enhance immunotherapy
WO2023239940A1 (en) 2022-06-10 2023-12-14 Research Development Foundation Engineered fcriib selective igg1 fc variants and uses thereof
US20240003871A1 (en) 2022-06-29 2024-01-04 FUJIFILM Cellular Dynamics, Inc. Ipsc-derived astrocytes and methods of use thereof
WO2024059787A1 (en) 2022-09-16 2024-03-21 St. Jude Children's Research Hospital, Inc. Disruption of asxl1 in t cells to enhance immunotherapy
WO2024130212A1 (en) 2022-12-16 2024-06-20 Turnstone Biologics Corp. Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors
WO2024186630A1 (en) 2023-03-03 2024-09-12 Henry Ford Health System Use of extracellular vesicles for the treatment of cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801545A (en) * 1983-05-19 1989-01-31 Plant Genetics, Inc. Enhanced somatic embryogenesis using maltose
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
GB8611818D0 (en) * 1986-05-15 1986-06-25 Shell Int Research Plant generation method
FI890917A (fi) * 1988-03-02 1989-09-03 Eidgenoess Tech Hochschule Foerfarande foer framstaellning av transgena vaexter.
ES2050369T3 (es) * 1989-05-12 1994-05-16 Pioneer Hi Bred Int Pistola de particulas mejorada.
EP0814166A3 (de) * 1989-08-09 1998-05-13 DeKalb Genetics Corporation Methoden und Zusammensetzungen für die Herstellung von stabil-transformierten, fruchtbaren monokotyledonen Pflanzen und Zellen dafür
EP0442174A1 (de) * 1990-02-13 1991-08-21 Pioneer Hi-Bred International, Inc. Stabile Transformation von Pflanzenzellen
AU8914291A (en) * 1990-11-23 1992-06-25 Plant Genetic Systems N.V. Process for transforming monocotyledonous plants
AU2515592A (en) * 1991-08-23 1993-03-16 University Of Florida A novel method for the production of transgenic plants
US5610042A (en) * 1991-10-07 1997-03-11 Ciba-Geigy Corporation Methods for stable transformation of wheat
WO1993007256A1 (en) * 1991-10-07 1993-04-15 Ciba-Geigy Ag Particle gun for introducing dna into intact cells
IL101119A0 (en) * 1992-03-03 1992-11-15 Univ Ramot Transgenic wheat

Also Published As

Publication number Publication date
ATE181364T1 (de) 1999-07-15
GR3031054T3 (en) 1999-12-31
DK0674715T3 (da) 1999-11-29
WO1994013822A3 (en) 1994-09-15
ES2134925T5 (es) 2007-06-01
DE69325389T2 (de) 1999-11-25
DK0674715T4 (da) 2007-02-19
EP0674715B2 (de) 2006-10-11
AU5749394A (en) 1994-07-04
US5955362A (en) 1999-09-21
US5610042A (en) 1997-03-11
AU688297B2 (en) 1998-03-12
CA2151127A1 (en) 1994-06-23
EP0674715A1 (de) 1995-10-04
WO1994013822A2 (en) 1994-06-23
EP0674715B1 (de) 1999-06-16
CA2151127C (en) 2008-03-25
ES2134925T3 (es) 1999-10-16
DE69325389T3 (de) 2007-02-08

Similar Documents

Publication Publication Date Title
DE69325389D1 (de) Verfahren zur stabile transformation von weizen
PT87394A (pt) Process for plant tissue transformation
DE3751923D1 (de) Verfahren zur Klonierung von Restriktions-Modifikationssystemen
ATE129925T1 (de) Verfahren zur in-line-hydrolyse von harnstoff.
DE69109306D1 (de) Stabile transformation von monokotylen pflanzenzellen durch elektoporation.
DE69333286D1 (de) Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren
ATE266093T1 (de) Zellkern-codiertes transkriptionssystem plastiden höherer pflanzen
ATE96032T1 (de) Verfahren zur herstellung von aloe-erzeugnissen.
ATE47271T1 (de) Verfahren zur aufzucht von lilien und ausgewachsene lilienpflanze des longiflorumtypus.
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
MY112975A (en) Mild refining of triglyceride oil
PT67829A (de) Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen,sowie verfahren zu seiner herstellung
ATE73498T1 (de) Verfahren zur transformation von pilzen mit einem vektor.
DE3888648D1 (de) Verfahren zur Herstellung von HgiAI-Restriktionsendonuklease und -methylase.
FI962549A (fi) Metallinen siirrännäinen ja menetelmä metallisen siirrännäisen käsittelemiseksi
DE3587651D1 (de) Verfahren zur Verbesserung des Wachstums bestimmter Pflanzen.
DE69528903D1 (de) Verfahren zur kalziumphosphat-transfektion
DE3776640D1 (de) Mittel zur verbesserung und natuerlichen gesunderhaltung von boeden und pflanzenwachstum sowie entsprechendes verfahren hierzu.
DE69019034D1 (de) Verfahren zur Produktion von Hybridpflanzen von Allium.
ES463092A1 (es) Procedimiento de obtencion de los compuestos 8-(1h-tetrazol-5-il)-11h pirido (2,1-b) quinazolin-11-onas, y las sales farmaceuticamente aceptables de acidos y bases de los mis- mos.
ES8602355A1 (es) Un procedimiento para transformar geneticamente semillas de plantas dicotiledoneas
DE69016249D1 (de) Verfahren zur elektrochemischen Behandlung von Schwefelwasserstoff enthaltendem Gas.
ATE211716T1 (de) Verfahren zur herstellung von feinverteiltes metallisches kobalt enthaltendem kobalt(ii)-oxid
DE58907981D1 (de) Verfahren zur Entschwefelung von Koksofengas.
ATE207885T1 (de) Verfahren zur herstellung von ethylenisch ungesättigten isocyanaten

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: SYNGENTA PARTICIPATIONS AG, BASEL, CH

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8366 Restricted maintained after opposition proceedings